IN THIS ISSUE:
- Effect of CNV Regression on Macular Atrophy in Anti-VEGF-Treated Eyes
- Role of Ranibizumab in Ischemic CRVO
- Management of Macular Swelling Following Cataract Surgery With Nepafenac 0.1% Plus Dexamethasone 0.1% vs. Dexamethasone Alone
- How Aganirsen Anti-Sense Oligonucleotide Eye Drops Affect Keratitis-Induced CNV and the Need for Transplantation
To subscribe to our optical e-newsletters and receive them via e-mail, click here.
Copyright© 2000 - 2014 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.